Announced Sun, 26 Jul · 21:12 IST
Newspaper ad of Q1 FY27 unaudited results published
Compliance View source PDF
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1649.00
prior close
₹1695.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-3.0-2.9-1.4——————————
Up moveDown movePending
AI summary
OneSource Specialty Pharma (formerly Stelis Biopharma) has informed exchanges that it published newspaper advertisements on July 26, 2026 in Financial Express and Lokmat, carrying extracts of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This is a routine SEBI-mandated public disclosure under Regulation 47 of the LODR rules; the detailed results were filed separately earlier.
Likely market impact
Routine compliance filing, no new financial information beyond what was already disclosed in the earlier results filing.